awmsg logo



idebenone (Raxone®)


Reference No. 807

Publication date:
11/01/2016


Appraisal information

idebenone (Raxone®) 150 mg film-coated tablet


Company: Chiesi Ltd
BNF category: Eye
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 06/01/2016

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, idebenone (Raxone®) cannot be endorsed for use within NHS Wales for the treatment of visual impairment in adolescent and adult patients with Leber’s hereditary optic neuropathy.
Statement of Advice (SOA)
Download